212 related articles for article (PubMed ID: 6199140)
1. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
[TBL] [Abstract][Full Text] [Related]
2. Chronic liver disease: the detection and characterization of circulating immune complexes.
Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen.
Brown SE; Howard CR; Steward MW; Viola L; Murray-Lyon IM
Dev Biol Stand; 1983; 54():391-7. PubMed ID: 6653894
[TBL] [Abstract][Full Text] [Related]
4. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
5. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
[TBL] [Abstract][Full Text] [Related]
6. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
8. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
[TBL] [Abstract][Full Text] [Related]
9. [IgM/HBsAG complexes in hepatitis B virus infections].
Almi P; Fanetti G; Toti M; Rubino M
Quad Sclavo Diagn; 1982 Sep; 18(3):340-4. PubMed ID: 7184047
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
11. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
Araki K; Nagashima H; Tsuji T
Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection.
Pernice W; Sodomann CP; Lüben G; Seiler FR; Sedlacek HH
Clin Exp Immunol; 1979 Aug; 37(2):376-80. PubMed ID: 91465
[TBL] [Abstract][Full Text] [Related]
14. [Immunoenzyme analysis of antigen-specific determination of HBsAG-containing circulating immune complexes (CIC HBsAG/IgM and CIC HBsAG/IgG) in blood serum of patients with HBV-infection].
Sokolenko AA; Shakhanina KL; Kurilov AN
Biull Eksp Biol Med; 1992 Feb; 113(2):174-6. PubMed ID: 1377044
[TBL] [Abstract][Full Text] [Related]
15. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
[TBL] [Abstract][Full Text] [Related]
16. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
17. Identification of HBsAg determinants in immune complexes from hepatitis B virus-associated vasculitis.
Gupta RC; Kohler PF
J Immunol; 1984 Mar; 132(3):1223-8. PubMed ID: 6198385
[TBL] [Abstract][Full Text] [Related]
18. Circulating HBsAg/IgM complexes in acute and chronic hepatitis B.
Musca A; Cordova C; Barnaba V; Zaccari C; Levrero M; van Dyke A; Balsano F
Hepatogastroenterology; 1984 Oct; 31(5):208-10. PubMed ID: 6510881
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma.
Wu CC; Ho WL; Chen JT; Tang JS; Yeh DC; P'eng FK
Br J Surg; 1999 Nov; 86(11):1391-6. PubMed ID: 10583284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
